pagiantmetknicksfan@yahoo.com
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Not sure I follow. If there is a speculation of a leak of information like one of the trial results being released, another drug launch, partnership etc.....then why would it go down? Doesn't mean the leak happened yesterday does it? Or that the item is supposed to happen today...does it?
or are you just saying that there are so many positive events due to happen anytime now and continue to occur thus the future is exciting?
Most stocks including Apple and every other stock I look at go up and down at some point. Does that mean every stock is flipped? Or do you mean people are just trading the stock?
Please point out some links to the "hype"?
Efficacy for a generic drug proven to be bioequivalent? why?
And still not one legitimate reason why Elite will not have any issues with any trials whatsoever or any reason to doubt the technology whatsoever or its ability to be transferred across Opioids.
ok? lol
You did the research to make these conclusions? What did your research tell you? Provide links. TIA...lol
You do realize that those four categories are not in preferential order...right?
You know what is funny?
You did not show anything to prove anything and you are wrong
Yeah not biting here....not sure they really are and if they are not sure why I should care.
Pisgah is weird. They may be great but it seems the articles I found were written by them or something...its not clear to me. Private company
Hey Couch...can you point me to the post below that discusses what the company is actually doing?
Or claim Elite should be valued based on current revenues.
Nah. I am good with my shares...
I love this company. I am here for the R&D. But trying to convince me there is not manipulation on OTC is not going to go far. It is the only thing you can count on in OTC.
Show me links
Manipulation is a fact. And R&D companies not being valued on current revenues is a fact unless many with large caps are worth 0.
And simple deduction would show you that I have been dead on accurate.
Projected...lol..so now you agree with me..
Last time I heard that, the stock went on a two month run to .97....
Tell me why you believe institutional buying is ongoing. ..lol
Funny thing is I am focused on what the Company is doing which has been quite remarkable.
Company is incredibly undervalued.
I do find your constant insistence that non retail...ie institutional buying is what is taking place quite interesting. I do agree the stock is going to run soon.
I have noticed the same non retail manipulation too. Funny how for all the retail selling claimed...The stock move up late last week on little volume....and that is actually a fact.
Laughing? Elite is undervalued by several X without any revenues....
you are correct
Gotcha....
Eaglet is interesting and they have cash but they also are losing 10m per Q and have almost twice as many shares as noted if diluted and zero revenues.
Elite's development costs are way lower and a real advantage as well as the generation of revenues to support costs. If anything Eaglet shows just how undervalued Elite currently is. That was just a quick look at it.
From a trial perpsective, it would seem they are pretty far behind ELite
Actually pretty much all of these things are happening or not relevant..lol
I have been told that M&A type folks are hard at work presenting false information while forcing the price down....LOL..Who do you think pays for those Hotstocked articles all year long...
I see false information continually presented. This is not an agree or disagree situation. This is truth or not truth.
As far as supply and demand, that is a product of manipulation. People will buy at .60 and be afraid at .20....Human nature and I will never understand it but one thing is clear...Your attempts at valuation have nothing to do with supply and demand and have been a presentation of false information...
See how things keep changing...Before it was dilution, then it was EPS, not it is supply and demand....
What if Elite had no revenues, what would they be worth? lol What was Elite cap in 2005 before they passed one trial and were strictly an R&D company? And before there was even much of a focus on ADT technology?
What you are posting is completely false
Trial results are proof of possible earnings...that is how it works in R&D companies. Again if you believe the product line, the trials, the technology and understand it, you understand that the stock is undervalued by many x right now.
That is how it works outside of OTC and the associated manipulation.
The share count hasn't changed much really in 4 reports....15% or so in a year so no idea what you are talking about on so many levels. And very little really the past couple reports
I see the same non retail MMs day after day doing the same things. The same big asks put up. The same misinformation etc....I know what is coming. I didnt even look at level 2 today and can tell you what it looked like and who was there...lol
This is OTC. The only thing you can count on is manipulation. But heck even Jim Kramer admitted to disseminating false information about stocks before he was on TV to get people to sell or not buy a stock....And that is on the big board stocks. Funny huh?
Really just manipulation right now by a handful or organized traders and MMs. That is pretty much obvious and all that is obvious outside of Elite being incredibly undervalued.
Find me a comparable company with R&D and positive trial results with numerous products in an $8b market and 20 approved generics, often with little competition and 10 more drugs pending approval or in development.
One where their operations are paid for by their current and rapidly growing revenues....let me know what you get.
Heck just separate the two and tell me the caps of each one.
If you think the stock price here is related to earnings....you will miss the boat....good luck with that hypothesis...What if Elite didnt have any revenue based products? Lots of drug companies out there that have no revenues or minimal compared to expenses. Cancer drugs are the big one now....caps in hundreds of millions of dollars..
Funny how EPS is now the topic of the day...when we all know it has nothing to do with the big picture or R&D pharma valuation
Except that never happened but otherwise you would be correct. lol
Yes all those promises of drug development and trials and all those successful trials and drugs developed...You do realize the company has done everything they said they would do...Do you have any evidence of pump and dump? You mean the continued increases in Q revenues YOY? lol
Both are possible but I also believe there are several factors. First you have the consistent trading down by traders manipulating the price and presentation of misinformation. Easy to do on low volume. The stock is heavily undervalued and this is obvious to all. So working the price down increases the money you make and decreases any risk but the MMs here are not your normal retail MMs.
I have also thought about the run to .97 and the shorting that likely occurred and the covering that ensues....What ran it .97? Only one person claims P&D and when asked for where the pump was, there is no answer. Even an article was written that claimed a pump but everyone that investigated it, found nothing.
Lots of money on the side that will buy the stock at .60 before they buy it at .20.
Price is the only thing that can be manipulated and logic would conflate price to company success but that would be false logic in the short term.
LOL @ EPS ...another red herring argument. First it was dilution, then it was retail selling, then it was dilution, now it is EPS....
Meanwhile products pending launch, Q coming up shortly with CC, and partnership discussions ongoing as we know.
I am done for tonight....I am sure the misinformation will be here tomorrow.
Here is a thought and maybe the most accurate speculation you will hear today. What if the same non retail MMs that ran the stock up to .97 have shorted it down over the past year and have continued this misinformation campaign (Hotstocked..etc.) over the past year to cover their shares until they can run it up again. Note the continued forcing of the stock down...
Often over the past few months, the same non retail MM on the ask when there is no one even close at times....hmmmm
Or it can be the continues non retail manipulation and shorting. If you are claiming dilution and they have $7.5m in cash and just got another 500k to $1m this month, how many more products are you saying are entering trials now? Which and what trials...
What do you think it will be? How many competitors do some of these drugs have?
Tell me what the drugs are, what the market is for them and how many competitors they have...then explain the revenue projections to me for them. That is how these things are done.
Say, how many Abuse deterrent products does Elite have in development now?